THE NANOTECHNOLOGY TEAM

We have assembled a world class team to lead us to success. We have brought together highly experienced individuals with strong expertise in their respective areas. Our team possesses the combined expertise of having performed research, development, and regulatory processing for over 25 drugs, of which 10 are approved and the rest are at various advanced clinical stages, at the team members' previous affiliations. Our team is also highly innovative, and boasts pioneering research in varied areas that are at the fore-fronts of medical science and pharmaceutical technology such as polymeric micelles, multi-specific multi-targeting, anti-sense DNA, siRNA, ribozymes, and gene therapy.

Executive Team

Anil R. Diwan, PhD - Chairman and President

Eugene Seymour, MD, MPH - Board Member & CEO

Ms. Meeta R. Vyas, MBA (Fin.), BS (Chem. Eng.) - interim Chief Financial Officer

Stanley Glick, BBA, CPA - Independent Board Member and Chairman of Audit Committee

Randall Barton, PhD - Chief Scientific Officer

Jayant Tatake, PhD - Vice President R&D

Krishna Menon, PhD, VMD, MRCS - Chief Regulatory Office, Consulting